Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

The future of regenerative therapy in patients with chronic heart failure

Nature Clinical Practice Cardiovascular Medicine volume 3, pages S133–S135 (2006)Cite this article

Abstract

Regenerative therapy is a rapidly growing branch of science and medicine, which could have an important impact on the treatment of heart failure, a major cause of disability and death. Regeneration of the damaged myocardium in heart failure can be achieved through different strategies aimed at 'reviving' existing malfunctioning cells, repopulating the myocardium by new cells from exogenous or endogenous sources, altering the extracellular matrix, or increasing blood supply by enhancing vasculogenesis. To date, the clinical application of some of these strategies has had minimal or no impact on the global epidemic of chronic heart failure. However, several small clinical trials have reported varying degrees of functional improvement which could be considerable in some cases. We here review recent progress in the field, suggest an integrated approach, and outline the many gaps in our knowledge which need to be resolved by intensive laboratory research if regenerative therapy for chronic heart failure is to achieve its future potential.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. McMurray JJ and Pfeffer MA (2005) Heart failure. Lancet 365: 1877–1889

    Article  Google Scholar 

  2. Yacoub M et al. (2004) C34T AMP deaminase 1 gene mutation protects cardiac function in donors. Transplantation 77: 1621–1623

    Article  CAS  Google Scholar 

  3. Yacoub MH (2001) A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. Eur Heart J 22: 534–540

    Article  CAS  Google Scholar 

  4. Mancini DM et al. (1998) Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 98: 2383–2389

    Article  CAS  Google Scholar 

  5. Terracciano CM et al. (2004) Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation 109: 2263–2265

    Article  CAS  Google Scholar 

  6. Soppa GK et al. (2005) Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle. Am J Physiol 288: H1468–H1476

    CAS  Google Scholar 

  7. Laugwitz KL et al. (2005) Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433: 647–653

    Article  CAS  Google Scholar 

  8. Orlic D et al. (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 98: 10344–10349

    Article  CAS  Google Scholar 

  9. Musaro A et al. (2004) Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. Proc Natl Acad Sci USA 101: 1206–1210

    Article  CAS  Google Scholar 

  10. Askari AT et al. (2003) Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362: 697–703

    Article  CAS  Google Scholar 

  11. Crystal RG (1995) Transfer of genes to humans: early lessons and obstacles to success. Science 270: 404–410

    Article  CAS  Google Scholar 

  12. Isner JM (2002) Myocardial gene therapy. Nature 415: 234–239

    Article  CAS  Google Scholar 

  13. Hayase M et al. (2005) Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade. Am J Physiol 288: H2995–H3000

    CAS  Google Scholar 

  14. Bekeredjian R et al. (2003) Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 108: 1022–1026

    Article  Google Scholar 

  15. Suzuki K et al. (2004) Enhanced effect of myocardial gene transfection by VP22-mediated intercellular protein transport. J Mol Cell Cardiol 36: 603–606

    Article  CAS  Google Scholar 

  16. Suzuki K et al. (2001) Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 104: I207–I212

    Article  CAS  Google Scholar 

  17. Kehat I et al. (2001) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108: 407–414

    Article  CAS  Google Scholar 

  18. He J-Q et al. (2003) Human embryonic stem cells develop into multiple types of cardiac myocytes. Action potential characterization. Circ Res 93: 32

    Article  CAS  Google Scholar 

  19. Kipshidze NN and Serruys PW (Eds; 2004) Handbook of Cardiovascular Cell Transplantation. London: Martin Dunitz

    Google Scholar 

  20. Dimmeler S et al. (2005) Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 115: 572–583

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Harefield Heart Science Centre, National Heart and Lung Institute, Imperial College London, Harefield, Middlesex, UK

    Magdi Yacoub, Ken Suzuki & Nadia Rosenthal

  2. Mouse Biology Unit, European Molecular Biology Laboratory, Monterotondo, Italy

    Nadia Rosenthal

Authors
  1. Magdi Yacoub
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ken Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nadia Rosenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Magdi Yacoub.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yacoub, M., Suzuki, K. & Rosenthal, N. The future of regenerative therapy in patients with chronic heart failure. Nat Rev Cardiol 3 (Suppl 1), S133–S135 (2006). https://doi.org/10.1038/ncpcardio0401

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0401

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing